Skip to main content
Article
Benzodiazepines I: Upping the Care on Downers: The Evidence of Risks, Benefits and Alternatives
Journal of Clinical Medicine
  • Jeffrey Guina, University of Michigan Medical School
  • Brian Merrill, Wright State University - Main Campus
Document Type
Article
Publication Date
1-1-2018
Identifier/URL
85114281827 (Scopus)
Abstract

Benzodiazepines are some of the most commonly prescribed medications in the world. These sedative-hypnotics can provide rapid relief for symptoms like anxiety and insomnia, but are also linked to a variety of adverse effects (whether used long-term, short-term, or as needed). Many patients take benzodiazepines long-term without ever receiving evidence-based first-line treatments (e.g., psychotherapy, relaxation techniques, sleep hygiene education, serotonergic agents). This review discusses the risks and benefits of, and alternatives to benzodiazepines. We discuss evidence-based indications and contraindications, and the theoretical biopsychosocial bases for effectiveness, ineffectiveness and harm. Potential adverse effects and drug-drug interactions are summarized. Finally, both fast-acting/acute and delayed-action/chronic alternative treatments for anxiety and/or insomnia are discussed. Response to treatment—whether benzodiazepines, other pharmacological agents, or psychotherapy—should be determined based on functional recovery and not merely sedation.

Comments
Copyright © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
DOI
10.3390/jcm7020017
Citation Information
Jeffrey Guina and Brian Merrill. "Benzodiazepines I: Upping the Care on Downers: The Evidence of Risks, Benefits and Alternatives" Journal of Clinical Medicine Vol. 7 Iss. 2 (2018)
Available at: http://works.bepress.com/brian-merrill/3/